This Gram-negative bacterium, which belongs to the Actinobacteria, is known for its ability to favourably modulate the balance of the microbiota. Indeed, Bifidobacterium infantis BIO2 contributes to the reduction of abdominal pain in patients suffering from Irritable Bowel Syndrome (IBS). In vivo studies have also shown that Bifidobacterium infantis helps to reduce anxiety in the case of stress-induced colonic hypersensitivity.
In addition, this bacterium has a beneficial effect on the immune system by reducing the imbalance between pro-inflammatory and anti-inflammatory cytokines. In addition, the combination of Bifidobacterium infantis and Lactobacillus acidophilus contributes effectively to the management of diarrhoea.